e-learning
resources
Stockholm 2007
Monday 17.09.2007
Aetiology, mechanisms and treatment in lower respiratory tract infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Etiology specifics of COPD bacteriological exacerbation with and without metatuberculosis pneumofibrosis
E. L. Mishustina, T. S. Ageeva, S. P. Mishustin (Tomsk, Russian Federation)
Source:
Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections
Session:
Aetiology, mechanisms and treatment in lower respiratory tract infections
Session type:
Thematic Poster Session
Number:
2391
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. L. Mishustina, T. S. Ageeva, S. P. Mishustin (Tomsk, Russian Federation). Etiology specifics of COPD bacteriological exacerbation with and without metatuberculosis pneumofibrosis. Eur Respir J 2007; 30: Suppl. 51, 2391
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Clinical and temporal characteristics of chronic bronchitis complicated with secondary bronchiectasis
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Pathogenesis and diagnosis of bronchiectasis
Source: Breathe 2010; 6: 342-351
Year: 2010
Pathomorphology of COPD
Source: Virtual Congress 2020 – Russian speaking programme 2020: Part I
Year: 2020
Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Clinical and inflammatory features of exacerbations of occupational chronic obstructive pulmonary disease
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017
Possibilities to control pulmonary hypertension in patients with COPD and pulmonary tuberculosis complicated by chronic cor pulmonale
Source: Eur Respir J 2003; 22: Suppl. 45, 423s
Year: 2003
Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease
Source: International Congress 2014 – COPD markers
Year: 2014
Clinical, morphological and immunological characteristics of patients with COPD and chronical bronchitis after tracheostomy
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Chronic obstructive pulmonary disease exacerbations: Impact of the GOLD stage or the presence of bronchiectasis on sputum microbiology
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis
Source: International Congress 2017 – COPD and weaning
Year: 2017
Microbiological screening infectious exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Clinical relevance of bronchiectasis in COPD
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010
Clinico-immunological characteristics of acute and exacerbations of chronic bronchitis in youths
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003
Influence of bronchiectasis in COPD exacerbations caused by
pseudomonas aeruginosa
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009
Chronic pulmonary aspergillosis in patients with post-tuberculosis bronchiectasis
Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Year: 2018
Induced sputum cytology at different etiology of exacerbation of chronic obstructive bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002
Chronic airflow obstruction in cases of new confirmed cavitary tuberculosis – Unrecognized COPD or disease manifestation?
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Pulmonary rehabilitation is more effective in subjects with chronic bronchitis than in those with emphysema
Source: Eur Respir J 2004; 24: Suppl. 48, 294s
Year: 2004
Definition and aetiology of infective exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 58-67
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept